| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Chief Commercial Officer | Stock Options | 150,000 | $634,500 | $4.23 | 13 Nov 2024 | Direct |
| FENNEC PHARMACEUTICALS INC. | Chief Commercial Officer | Restricted Share Unit | 160,000 | 28 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC. | 28 Mar 2025 | 1 | $0 | 4/A | Chief Commercial Officer | 03 Apr 2025, 19:14 |
| FENC | FENNEC PHARMACEUTICALS INC. | 13 Nov 2024 | 1 | +$634,500 | 4 | Chief Commercial Officer | 13 Nov 2024, 17:14 |
| FENC | FENNEC PHARMACEUTICALS INC. | 28 Oct 2024 | 0 | $0 | 3 | Chief Commercial Officer | 04 Nov 2024, 16:31 |